4.5 Article

Interactive Effects of μ-Opioid and Adrenergic-α2 Receptor Agonists in Rats: Pharmacological Investigation of the Primary Kratom Alkaloid Mitragynine and Its Metabolite 7-Hydroxymitragynine

Related references

Note: Only part of the references are listed.
Review Neurosciences

Pain management with opioids in adults

Lori S. Montgomery

Summary: Despite the widespread use of opioids in pain management, there is a lack of convincing clinical data on their long-term effectiveness. It is crucial to clarify the evidence-based indications for opioid therapy to address negative consequences and maximize therapeutic benefits.

JOURNAL OF NEUROSCIENCE RESEARCH (2022)

Article Pharmacology & Pharmacy

The Lack of Contribution of 7-Hydroxymitragynine to the Antinociceptive Effects of Mitragynine in Mice: A Pharmacokinetic and Pharmacodynamic StudyS

Erin C. Berthold et al.

Summary: In this study, the analgesic effects, pharmacokinetics, and tissue distribution of Mitragynine (MTG) and its active metabolite 7hydroxymitragynine (7HMG) in mice were investigated. Results showed that 7HMG was more potent in producing analgesic effects compared to MTG, but as a metabolite of MTG, its brain concentration was significantly lower. Therefore, 7HMG has a negligible role in the analgesic effects of MTG.

DRUG METABOLISM AND DISPOSITION (2022)

Article Pharmacology & Pharmacy

The respiratory depressant effects of mitragynine are limited by its conversion to 7-OH mitragynine

Rob Hill et al.

Summary: The study found differential effects of Mitragynine and its metabolite, 7-OH Mitragynine, on mouse respiration and anti-nociception. Mitragynine showed a ceiling effect on respiratory depression, while 7-OH Mitragynine had dose-dependent effects. Inhibition of CYP3A reduced the respiratory depressant effects and anti-nociception induced by Mitragynine, but had no effect on the effects of 7-OH Mitragynine. These findings suggest that metabolic saturation may contribute to the improved safety profile of Mitragynine.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Article Cell Biology

Kratom Alkaloids, Natural and Semi-Synthetic, Show Less Physical Dependence and Ameliorate Opioid Withdrawal

Lisa L. Wilson et al.

Summary: The study confirmed the medicinal value of Thai traditional tea kratom, showing that kratom and its alkaloids can reduce dependence on opioids and alleviate withdrawal symptoms.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2021)

Article Pharmacology & Pharmacy

Pharmacological Comparison of Mitragynine and 7-Hydroxymitragynine: In Vitro Affinity and Efficacy for μ-Opioid Receptor and Opioid-Like Behavioral Effects in Ratss

Samuel Obeng et al.

Summary: The study revealed significant differences in the efficacy of MOR, with mitragynine having lower efficacy than 7-hydroxymitragynine.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2021)

Article Chemistry, Medicinal

Oxidative Metabolism as a Modulator of Kratom's Biological Actions

Soumen Chakraborty et al.

Summary: The main alkaloid of kratom, mitragynine, is metabolized in mice to form three different substances, 7-hydroxymitragynine, mitragynine pseudoindoxyl, and 3-dehydromitragynine, each with distinct pharmacological properties and effects. The oxidative metabolism of mitragynine may play a significant role in its overall pharmacology in vivo.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Public, Environmental & Occupational Health

Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths - United States, 2013-2019

Christine L. Mattson et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Article Substance Abuse

Race, pain, and opioids among patients with chronic pain in a safety-net health system

Nimah Haq et al.

Summary: This study evaluated racial disparities in opioid prescribing and stewardship among Black and White patients with chronic non-cancer pain. Findings showed that Black patients had lower past-year maximum opioid doses despite higher average pain and less injection drug use. This disparity may suggest bias in prescribing opioids for chronic pain among Black patients.

DRUG AND ALCOHOL DEPENDENCE (2021)

Article Chemistry, Medicinal

Novel Approaches, Drug Candidates, and Targets in Pain Drug Discovery

Samuel Obeng et al.

Summary: This review summarizes various targets for pain signaling and strategies for reducing side effects, increasing potency, and efficacy in drug development efforts, aiming to propel the discovery of novel analgesics.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Multidisciplinary Sciences

Evaluating kratom alkaloids using PHASE

Christopher R. Ellis et al.

PLOS ONE (2020)

Article Chemistry, Analytical

CYP450-Mediated Metabolism of Mitragynine and Investigation of Metabolites in Human Urine

Stephanie Basiliere et al.

JOURNAL OF ANALYTICAL TOXICOLOGY (2020)

Article Chemistry, Medicinal

Metabolism of a Kratom Alkaloid Metabolite in Human Plasma Increases Its Opioid Potency and Efficacy

Shyam H. Kamble et al.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)

Article Substance Abuse

Lyophilized Kratom Tea as a Therapeutic Option for Opioid Dependence

Lisa L. Wilson et al.

DRUG AND ALCOHOL DEPENDENCE (2020)

Article Chemistry, Multidisciplinary

7-Hydroxymitragynine Is an Active Metabolite of Mitragynine and a Key Mediator of Its Analgesic Effects

Andrew C. Kruegel et al.

ACS CENTRAL SCIENCE (2019)

Article Pharmacology & Pharmacy

The Effects of Morphine, Baclofen, and Buspirone Alone and in Combination on Schedule-Controlled Responding and Hot Plate Antinociception in Rats

Jenny L. Wilkerson et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)

Article Veterinary Sciences

Alternatives to Opioid Analgesia in Small Animal Anesthesia: Alpha-2 Agonists

Alexander Valverde et al.

VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE (2019)

Article Anesthesiology

Additives used to reduce perioperative opioid consumption 1: Alpha2-agonists

Peter H. Tonner

BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY (2017)

Article Pharmacology & Pharmacy

The Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model

Jenny L. Wilkerson et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)

Article Toxicology

Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine

Alicia G. Lydecker et al.

JOURNAL OF MEDICAL TOXICOLOGY (2016)

Article Neurosciences

Discriminative stimulus properties of mitragynine (kratom) in rats

Norsyifa Harun et al.

PSYCHOPHARMACOLOGY (2015)

Article Substance Abuse

Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users

Darshan Singh et al.

DRUG AND ALCOHOL DEPENDENCE (2014)

Article Medicine, General & Internal

The Potential for Misuse and Abuse of Medications in ADHD: A Review

David B. Clemow et al.

POSTGRADUATE MEDICINE (2014)

Article Biochemistry & Molecular Biology

Antinociceptive Action of Isolated Mitragynine from Mitragyna Speciosa through Activation of Opioid Receptor System

Abdul Rahman Shamima et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)

Article Pharmacology & Pharmacy

Involvement of imidazoline and opioid receptors in the enhancement of clonidine-induced analgesia by sulfisoxazole

Mustufa Boxwalla et al.

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2010)

Review Chemistry, Medicinal

alpha(2)-Agonists as Analgesic Agents

Maria Paola Giovannoni et al.

MEDICINAL RESEARCH REVIEWS (2009)

Review Chemistry, Medicinal

Interest of alpha(2)-adrenergic agonists and antagonists in clinical practice: Background, facts and perspectives

Pierre-Antoine Crassous et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)

Article Pharmacology & Pharmacy

An overview of drug combination analysis with isobolograms

Ronald J. Tallarida

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)